Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Tibet Rhodiola Pharmaceutical Holding Co. on 6ix
Earlier from Tibet Rhodiola Pharmaceutical
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025
Later from Tibet Rhodiola Pharmaceutical
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
- Announcement on Resolutions of the 11th Meeting of the 8th Board of Directors
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Outline of the Q3 2025 Performance Briefing
- Announcement on the Continued Inclusion of the Company’s Product Xinhuaosu in the National Medical Insurance Drug Catalog
Follow Tibet Rhodiola Pharmaceutical into a list and get an email when it puts out news.
Follow Tibet Rhodiola Pharmaceutical